Evaluate and follow up SLE (systemic lupus erythematosus) patient's response to therapy; may predict disease flare in SLE; evaluate for complement component deficiency; evaluate complement activity in cases of immune complex disease, glomerulonephritis, rheumatoid arthritis, SBE, cryoglobulinemia. The CH50 assay mainly evaluates the classical pathway.
Immediately following collection, thoroughly mix sample by gently inverting 5 times
Frozen (strict) - 14 days
Freeze/thaw cycles - stable x 3
Ambient - NO
Refrigerated - NO
Quantitative liposome lysis by spectrophotometry
Age |
Male (U/mL) |
Female (U/mL) |
1 – 30 d |
Not established |
Not established |
31 d – 6 m |
> 32 |
> 20 |
7 m – 17 y |
> 39 |
> 39 |
> 17 y |
> 41 |
> 41 |